RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Palo Alto, CA · Sacramento, CA · +49 more sites
Crohn's Disease clinical trials in Palo Alto, CA
5 recruiting crohn's disease studies with a site in Palo Alto, CA.
RecruitingNot applicableNCT05230173
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Sponsor: Mayo Clinic
Irvine, CA · La Jolla, CA · Los Angeles, CA · +21 more sites
RecruitingPhase 3NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Sponsor: Takeda
Loma Linda, CA · Orange, CA · Palo Alto, CA · +11 more sites
RecruitingPhase 2 / Phase 3NCT05660746
Precise Infliximab Exposure and Pharmacodynamic Control
Sponsor: Children's Hospital Medical Center, Cincinnati
Los Angeles, CA · Palo Alto, CA · San Diego, CA · +8 more sites
Not yet recruitingPhase 1 / Phase 2NCT06986382
Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease
Sponsor: Stanford University
Palo Alto, CA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.